The current price of GH is $157.40 — it has decreased by 6.63% since the previous close. Data as of Nov 5, 2026.
GH is down 14.47% over the past week, down 16.64% over the past month and up 64.20% over the past year. The price is above its 200-day moving average of $131.37.
Of the 26 analysts covering Guardant Health, Inc., 4 rate it a strong buy, 21 rate it a buy and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Guardant Health, Inc. has a market capitalization of $21.12B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Guardant Health, Inc. posted a loss of $0.90 per share against an estimate of -$0.7618, missing expectations by 18.14%. Upcoming reports are listed in the earnings calendar.
Guardant Health, Inc. reported revenue of $334.98M in its most recent quarter, which has increased by 44.33% compared with the same quarter a year earlier. Analysts had expected $314.23M.
In the latest trading session GH moved between $151.92 and $165.10, a range of 8.37% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Guardant Health, Inc. shows a sell rating today and a neutral rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Guardant Health, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GH has traded between $74.55 and $191.05. The current price is 17.61% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.